 The expert consensus recommendation for topical maintenance dosing for recurrent vulvovaginal candidiasis, RVDC, is to use clotrimazole, myconazole, turconazole, or intravaginal boric acid, with fluconazole, ebrexifunger, and intravaginal boric acid being avoided during pregnancy. The initial full course of treatment should be followed by topical maintenance beginning at one to three times weekly, based on chosen agent, with twice a week dosing being the regimen most often utilized. Episodic treatment may be used in some women, but maintenance should remain an option for this population. This article was authored by Nancy A. Phillips, Gloria Bachman, Hope Hafner, and others.